| γH2AX: a sensitive molecular marker of DNA damage and repair LJ Mah, A El-Osta, TC Karagiannis Leukemia 24 (4), 679-686, 2010 | 1303 | 2010 |
| Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K R Courtnay, DC Ngo, N Malik, K Ververis, SM Tortorella, TC Karagiannis Molecular biology reports 42, 841-851, 2015 | 504 | 2015 |
| Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents K Ververis, A Hiong, TC Karagiannis, PV Licciardi Biologics: Targets and Therapy, 47-60, 2013 | 372 | 2013 |
| Transferrin receptor-mediated endocytosis: a useful target for cancer therapy S Tortorella, TC Karagiannis The Journal of membrane biology 247, 291-307, 2014 | 339 | 2014 |
| Clonogenic assay: adherent cells H Rafehi, C Orlowski, GT Georgiadis, K Ververis, A El-Osta, ... JoVE (Journal of Visualized Experiments), e2573, 2011 | 297 | 2011 |
| Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells L Pirola, A Balcerczyk, RW Tothill, I Haviv, A Kaspi, S Lunke, M Ziemann, ... Genome research 21 (10), 1601-1615, 2011 | 232 | 2011 |
| Dietary sulforaphane in cancer chemoprevention: the role of epigenetic regulation and HDAC inhibition SM Tortorella, SG Royce, PV Licciardi, TC Karagiannis Antioxidants & redox signaling 22 (16), 1382-1424, 2015 | 223 | 2015 |
| RNA interference and potential therapeutic applications of short interfering RNAs TC Karagiannis, A El-Osta Cancer gene therapy 12 (10), 787-795, 2005 | 168 | 2005 |
| γH2AX as a molecular marker of aging and disease LJ Mah, A El-Osta, TC Karagiannis Epigenetics 5 (2), 129-136, 2010 | 150 | 2010 |
| The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression E Pitsillou, SM Bresnehan, EA Kagarakis, SJ Wijoyo, J Liang, A Hung, ... Molecular biology reports 47, 753-770, 2020 | 140 | 2020 |
| Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds? TC Karagiannis, A El-Osta Leukemia 21 (1), 61-65, 2007 | 124 | 2007 |
| Modulation of cellular radiation responses by histone deacetylase inhibitors TC Karagiannis, A El-Osta Oncogene 25 (28), 3885-3893, 2006 | 119 | 2006 |
| Derivative of bardoxolone methyl, dh404, in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improves diabetic kidney disease SM Tan, A Sharma, N Stefanovic, DYC Yuen, TC Karagiannis, C Meyer, ... Diabetes 63 (9), 3091-3103, 2014 | 112 | 2014 |
| DNA damage repair and transcription: Double-strand breaks: signaling pathways and repair mechanisms TC Karagiannis, A El-Osta Cellular and Molecular Life Sciences CMLS 61, 2137-2147, 2004 | 102 | 2004 |
| Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments TC Karagiannis, H Kn, A El-Osta Oncogene 26 (27), 3963-3971, 2007 | 96 | 2007 |
| Introduction to the molecular basis of cancer metabolism and the Warburg effect DC Ngo, K Ververis, SM Tortorella, TC Karagiannis Molecular biology reports 42, 819-823, 2015 | 95 | 2015 |
| Controversies surrounding the clinical potential of cinnamon for the management of diabetes H Rafehi, K Ververis, TC Karagiannis Diabetes, Obesity and Metabolism 14 (6), 493-499, 2012 | 95 | 2012 |
| The Warburg effect: molecular aspects and therapeutic possibilities H Ngo, SM Tortorella, K Ververis, TC Karagiannis Molecular biology reports 42, 825-834, 2015 | 92 | 2015 |
| Histone deacetylase inhibition and dietary short-chain fatty acids PV Licciardi, K Ververis, TC Karagiannis International Scholarly Research Notices 2011, 2011 | 92 | 2011 |
| Genetic and epigenetic events in diabetic wound healing H Rafehi, A El‐Osta, TC Karagiannis International wound journal 8 (1), 12-21, 2011 | 86 | 2011 |
